Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE) – Study protocol from a randomized controlled trial

被引：0
|
作者：
Josefin Sundh
Anders Magnuson
Scott Montgomery
Pontus Andell
Gustaf Rindler
Ole Fröbert
机构：
[1] Örebro University,Department of Respiratory Medicine, Faculty of Medicine and Health
[2] Örebro University,Clinical Epidemiology and Biostatistics
[3] Karolinska Institutet,Clinical Epidemiology Division, Department of Medicine
[4] University College London,Department of Epidemiology and Public Health
[5] Karolinska Institutet,Unit of Cardiology, Department of Medicine
[6] Karolinska University Hospital,Heart and Vascular Division
[7] Lekeberg Primary Health Care Centre,Department of Cardiology, Faculty of Medicine and Health
[8] Örebro University,undefined
来源：
Trials | / 21卷
关键词：
Beta-blocker; Cardiovascular event; COPD; Exacerbation; Mortality; Pragmatic randomized trial; Real-world evidence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Beta-blockers Reduce Mortality in Patients With Heart Failure or Ischemic Heart Disease and Chronic Obstructive Pulmonary Disease
    Ruzieh, Mohammed
    Baugh, Aaron
    Jebbawi, Lama
    Foy, Andrew J.
    CIRCULATION, 2020, 142
  • [22] Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers
    Chapman, Kenneth R.
    Wise, Robert A.
    Scirica, Benjamin M.
    Bhatt, Deepak L.
    Daoud, Sami Z.
    Lythgoe, Dan
    Garcia Gil, Esther
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [23] Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers
    Kenneth R. Chapman
    Robert A. Wise
    Benjamin M. Scirica
    Deepak L. Bhatt
    Sami Z. Daoud
    Dan Lythgoe
    Esther Garcia Gil
    Respiratory Research, 22
  • [24] Tolerability of beta-blockers in heart failure patients with associated chronic obstructive pulmonary disease - myth or reality?
    Dan, G. -A.
    Dan, A. R.
    Gologanu, D.
    Buzea, A.
    Dobranici, M.
    EUROPEAN HEART JOURNAL, 2007, 28 : 520 - 521
  • [25] Effects of home-based prescribed pulmonary exercise by patients with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial
    Liu, Xiaodan
    Li, Peijun
    Xiao, Lu
    Lu, Yufan
    Li, Ning
    Wang, Zhengrong
    Duan, Hongxia
    Li, Jian
    Wu, Weibing
    TRIALS, 2019, 20 (1)
  • [26] Effects of home-based prescribed pulmonary exercise by patients with chronic obstructive pulmonary disease: study protocol for a randomized controlled trial
    Xiaodan Liu
    Peijun Li
    Lu Xiao
    Yufan Lu
    Ning Li
    Zhengrong Wang
    Hongxia Duan
    Jian Li
    Weibing Wu
    Trials, 20
  • [27] A multidisciplinary telehealth program in patients with combined chronic obstructive pulmonary disease and chronic heart failure: study protocol for a randomized controlled trial
    Bernocchi, Palmira
    Scalvini, Simonetta
    Galli, Tiziana
    Paneroni, Mara
    Baratti, Doriana
    Turla, Ottavia
    La Rovere, Maria Teresa
    Volterrani, Maurizio
    Vitacca, Michele
    TRIALS, 2016, 17
  • [28] A multidisciplinary telehealth program in patients with combined chronic obstructive pulmonary disease and chronic heart failure: study protocol for a randomized controlled trial
    Palmira Bernocchi
    Simonetta Scalvini
    Tiziana Galli
    Mara Paneroni
    Doriana Baratti
    Ottavia Turla
    Maria Teresa La Rovere
    Maurizio Volterrani
    Michele Vitacca
    Trials, 17
  • [29] beta-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease
    Rutten, Frans H.
    FUTURE CARDIOLOGY, 2011, 7 (01) : 43 - 53
  • [30] Starting beta-blockers during exacerbations of chronic obstructive pulmonary disease Author reply
    Neef, Pieter A.
    Burrell, Louise M.
    McDonald, Christine F.
    Irving, Louis B.
    Johnson, Douglas F.
    Steinfort, Daniel P.
    INTERNAL MEDICINE JOURNAL, 2018, 48 (02) : 228 - 229
12345